Mobility

product on market Other (e.g. tea bag) GNC TriFlex Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Mobility
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Caplet(s)
Serving Size
30
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Fast-Acting Mobility Blend
250 mg
Apres-Flex
100 mg
Market median: 100.0mg (173 products)

Other Ingredients

Dicalcium Phosphate Cellulose Titanium Dioxide Vegetable Acetoglycerides Sodium Copper Chlorophyllin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

TWO PER DAY

Directions: As a dietary supplement, take two caplets daily. For best results, take one caplet twice daily.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN.

WARNING: Consult your physician prior to using this product if you are pregnant, nursing, taking medication, or have a medical condition.

Discontinue use two weeks prior to surgery.

Additional Information

Store in a cool, dry place.

-Improves joint movement in just 5 days** -5 times greater improvement in joint stiffness** -Enhances flexibility by 30% with just two small pills per day^*

CODE 282312 GNG

67% SMALLER PILL*

*Compared to a leading brand.

Metadata

Product Details

UPC / SKU0 48107 11865 5
DSLD Entry Date2013-03-25
Product TypeOther Combinations
FormOther (e.g. tea bag)
DSLD ID19436
Data Updated2026-04-11
Research

Research Evidence

14
Research Sources
50
Avg Quality
9
Rct
3
Clinical Trial
1
Systematic Review
1
Guideline
B Dressings and topical agents containing hyaluronic acid for chronic wound healing
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
B Effect of laughter exercise versus 0.1% sodium hyaluronic acid on ocular surface discomfort in dry eye disease: non-inferiority randomised controlled trial
Rct BMJ (Clinical research ed.) 2024 PubMed DOI
B Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach.
Guideline Aging clinical and experimental research 2026 PubMed DOI
C The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial
Rct Nutrients 2024 PubMed DOI
C Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices.
Rct African health sciences PubMed DOI
C The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain: An 8-week randomized double-blind placebo-controlled trial.
Rct Medicine PubMed DOI
C Liquid combination of hyaluronan, glucosamine, and chondroitin as a dietary supplement for knee osteoarthritis patients with moderate knee pain: A randomized controlled study.
Rct Medicine PubMed DOI
C Oral preparation of hyaluronic acid, chondroitin sulfate, N-acetylglucosamine, and vitamin C improves sexual and urinary symptoms in participants with recurrent urinary tract infections: a randomized crossover trial.
Rct The journal of sexual medicine PubMed DOI
C PMCF Study to Evaluate Performance and Safety of 'Hyaluronic Acid (HA)-Based Eyedrops' Used to Relieve Dry Eye Symptoms
Clinical Trial ClinicalTrials.gov 2022
C Effect of Hyaluronic Acid Oral Supplementation on Sexual and Urinary Symptoms of Women With Recurrent Urinary Tract Infections
Clinical Trial ClinicalTrials.gov 2022
View all evidence for Hyaluronic Acid →
Compare

Similar Products

View all Hyaluronic Acid products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.